“New U.S. Military Policy Requires Testosterone Screening”

The U.S. Department of Defense has released detailed instructions on a new mandatory testosterone deficiency screening policy for active-duty and reserve service members aged 30 and above. This policy, announced by U.S. Secretary of War Pete Hegseth in July, aims to enhance military readiness by identifying and managing hormonal and energy-related issues through standardized screening and treatment protocols for both men and women. Hegseth’s advocacy for testosterone usage has sparked discussions among experts regarding the scientific rationale behind such a directive. The U.S. Food and Drug Administration is planning a meeting in mid-September to discuss the medical application of testosterone. The guidelines require mandatory testosterone blood tests for men aged 30 and older, with younger men undergoing testing upon request or if warning signs are noted by medical professionals. While routine testosterone testing is not mandated for women, screening for symptoms like fatigue and irregular menstrual cycles is recommended to address hormonal imbalances and related conditions affecting energy levels. The guidance also outlines circumstances where off-label testosterone prescriptions may be appropriate for women, particularly postmenopausal individuals experiencing significantly reduced sexual desire. Some medical practitioners have expressed concerns that widespread testosterone testing could result in unnecessary or potentially harmful treatments, emphasizing the lack of substantial evidence supporting the notion that universal screening for low testosterone levels among military personnel would enhance U.S. combat readiness.